Core Viewpoint - The controlling shareholder of Langzi Co., Ltd. has pledged 20.77 million shares due to personal funding needs, raising concerns about the company's financial stability and operational performance [1][3]. Share Pledge Details - The pledged shares include 9.5 million shares to China International Capital Corporation and 11.27 million shares to CITIC Securities, with a pledge period starting from January 27, 2026, for one year [1][2]. - The total pledged shares represent 36.61% of the shareholder's holdings and 17.5% of the company's total equity [3]. Financial Performance - Langzi Co., Ltd. expects a net profit of 900 million to 1.05 billion yuan for 2025, a significant increase of 245.25% to 302.8% year-on-year, primarily due to investment gains from Ruoyuchen [6]. - The company's revenue for the first three quarters of 2025 was 4.328 billion yuan, remaining stable compared to the previous year, while the net profit excluding non-recurring items decreased by 4.11% [6][7]. Business Segments - The medical beauty segment generated approximately 2.237 billion yuan in revenue, a 2.49% increase year-on-year, but the corresponding net profit decreased by 33.49% [7]. - The women's clothing segment achieved revenue of 1.407 billion yuan, with a slight net profit increase of 1.62% [7]. - The children's wear segment contributed 674 million yuan in revenue, showing a decline compared to the previous year [7]. Inventory and Cash Flow - As of September 2025, the company's inventory for women's clothing reached approximately 630 million yuan, a 13.84% increase from the end of 2024 [7]. - The company's cash flow from operating activities decreased by 1.87% to 359 million yuan [6]. Strategic Moves - Langzi Co., Ltd. is accelerating its investment in the medical beauty sector, including a recent acquisition of a 67.5% stake in a cosmetic surgery hospital for 92.475 million yuan [8][9]. - The company controls four comprehensive hospitals and two outpatient departments, with plans to integrate these medical beauty institutions into its financial statements [9]. Financial Constraints - As of September 2025, the company's cash reserves were 505 million yuan, insufficient to cover short-term borrowings of 1 billion yuan [11].